KEZAR LIFE SCIENCES INC's ticker is KZR and the CUSIP is 49372L100. A total of 77 filers reported holding KEZAR LIFE SCIENCES INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $807,341 | -57.6% | 678,438 | -12.7% | 0.00% | -60.0% |
Q2 2023 | $1,903,743 | +6.4% | 777,038 | +36.0% | 0.01% | 0.0% |
Q1 2023 | $1,788,413 | +823.4% | 571,378 | +1976.8% | 0.01% | +400.0% |
Q4 2022 | $193,684 | -73.5% | 27,512 | -67.6% | 0.00% | -50.0% |
Q3 2022 | $731,000 | -13.9% | 84,854 | -17.3% | 0.00% | -33.3% |
Q2 2022 | $849,000 | -90.3% | 102,600 | -80.5% | 0.00% | -88.5% |
Q1 2022 | $8,738,000 | +4.6% | 525,772 | +5.3% | 0.03% | +44.4% |
Q4 2021 | $8,352,000 | +495.7% | 499,523 | +207.8% | 0.02% | +500.0% |
Q3 2021 | $1,402,000 | +168.1% | 162,302 | +68.7% | 0.00% | +200.0% |
Q2 2021 | $523,000 | -53.2% | 96,225 | -48.6% | 0.00% | -66.7% |
Q1 2021 | $1,117,000 | +12.8% | 187,352 | -1.2% | 0.00% | 0.0% |
Q4 2020 | $990,000 | -8.2% | 189,703 | -14.9% | 0.00% | -25.0% |
Q3 2020 | $1,079,000 | -19.2% | 222,871 | -13.5% | 0.00% | -42.9% |
Q2 2020 | $1,335,000 | +165.9% | 257,687 | +123.9% | 0.01% | +75.0% |
Q1 2020 | $502,000 | +41.0% | 115,079 | +29.8% | 0.00% | +300.0% |
Q4 2019 | $356,000 | -11.0% | 88,664 | -27.4% | 0.00% | 0.0% |
Q3 2019 | $400,000 | +61.3% | 122,064 | +280.0% | 0.00% | 0.0% |
Q2 2019 | $248,000 | +21.0% | 32,119 | +177.5% | 0.00% | 0.0% |
Q1 2019 | $205,000 | – | 11,575 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Prosight Management, LP | 3,200,000 | $10,016,000 | 4.75% |
Qiming U.S. Ventures Management, LLC | 828,711 | $2,593,865 | 3.14% |
SPHERA FUNDS MANAGEMENT LTD. | 1,888,228 | $5,910,154 | 0.99% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 6,887,591 | $21,558,160 | 0.91% |
Avidity Partners Management LP | 6,519,400 | $20,405,722 | 0.68% |
Ikarian Capital, LLC | 841,596 | $2,634,195 | 0.60% |
Opaleye Management Inc. | 625,000 | $1,956,250 | 0.59% |
CHI Advisors LLC | 689,451 | $2,157,982 | 0.57% |
Orbimed Advisors | 5,463,000 | $17,099,190 | 0.34% |
Palo Alto Investors LP | 656,200 | $2,053,906 | 0.17% |